Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma | MicrobiomeTrials← Back to trialsNCT02337985
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin Lymphoma
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2015-11-20Est. Completion: 2027-08-09
Enrollment target: 10 participants Locations- NCI Lymphoid Malignancies Branch, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
Adult Burkitt Lymphoma
This phase II trial studies how well epcoritamab works in combination with the chemotherapy regimen dose adjusted etopos…
New York, United StatesEst. completion May 30, 2031
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic LymphomaRecurrent Adult Hodgkin LymphomaRecurrent Adult Non-Hodgkin LymphomaRecurrent Burkitt LymphomaRecurrent Follicular Lymphoma
Stage III Follicular Lymphoma
Stage III Mantle Cell Lymphoma
Stage IV Follicular Lymphoma
Stage IV Mantle Cell Lymphoma
This phase I/II trial studies the side effects and best dose of gene therapy in treating patients with human immunodefic…
La Jolla, United StatesEst. completion May 13, 2021